Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis

BACKGROUND AND OBJECTIVES: Long lasting immune response to anti-SARS-CoV-2 vaccination in people with Multiple Sclerosis (pwMS) is still largely unexplored. Our study aimed at evaluating the persistence of the elicited amount of neutralizing antibodies (Ab), their activity and T cell response after...

Descripción completa

Detalles Bibliográficos
Autores principales: Maglione, Alessandro, Francese, Rachele, Arduino, Irene, Rosso, Rachele, Matta, Manuela, Rolla, Simona, Lembo, David, Clerico, Marinella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318111/
https://www.ncbi.nlm.nih.gov/pubmed/37409134
http://dx.doi.org/10.3389/fimmu.2023.1205879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318111/
https://www.ncbi.nlm.nih.gov/pubmed/37409134
http://dx.doi.org/10.3389/fimmu.2023.1205879

Ejemplares similares